Velimir Micovic, MD
Pain Medicine · Fort Myers, FLNPI 1265422794
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 79.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $7,542 and has fallen 94.1% since, to $445 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $85.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Relievant Medsystems, Inc.$1K
- Boston Scientific$862
- AbbVie$513
- Vertos Medical, Inc.$238
- Radius Health, Inc.$215
- plus $1K from 20 others
Across 18 payments — averaging $1952.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$35K
What the payments were for
- Speaking & faculty fees$9,30548%
- Travel & lodging$1,5558%
- Food & beverage$8,55044%
- Entertainment$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 115 | $15,353 |
| Relievant Medsystems, Inc. | 9 | $1,055 |
| Boston Scientific | 19 | $862 |
| AbbVie(2 entities) | 31 | $513 |
| Vertos Medical, Inc. | 4 | $238 |
| Radius Health, Inc. | 8 | $215 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $207 |
| Scilex Pharmaceuticals Inc. | 8 | $156 |
| Nalu Medical, Inc. | 1 | $148 |
| Nevro Corp. | 1 | $133 |
| Nutech Spine, Inc. | 1 | $120 |
| Stimwave Technologies Incorporated | 2 | $99 |
| Saluda Medical Americas, Inc. | 1 | $78 |
| Novartis | 2 | $42 |
| Flowonix Medical Incorporated | 1 | $35 |
| Lilly USA, LLC | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Spinal Simplicity, LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Abbott | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$4,633
- Intracept$3,304
- RESTORESENSORSURESCAN$2,500
- INTELLIS ADAPTIVESTIM$1,087
- VANTA ADAPTIVESTIM$940
- SYNCHROMEDII$413
- KYPHON Balloon Kyphoplasty$161
- Nalu Neurostimulation System$148
- mild Device Kit$144
- Vanta$135
- Senza$133
- SiFix$120
- NURO$110
How this compares
$19,445 in reported general payments places this provider in the 90th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,820 | $82,912 |
| Xtampza ErOxycodone Myristate | 128 | $69,476 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,756 | $60,237 |
| OxycontinOxycodone Hcl | 82 | $52,131 |
| Buprenorphine | 235 | $49,563 |
| Nucynta ErTapentadol Hcl | 30 | $39,286 |
| NucyntaTapentadol Hcl | 21 | $31,651 |
| Morphine Sulfate ErMorphine Sulfate | 1,018 | $29,501 |
| BotoxOnabotulinumtoxina | 16 | $20,396 |
| Fentanyl | 210 | $19,490 |
| Oxycodone Hcl | 1,063 | $19,363 |
| Morphine Sulfate | 457 | $14,131 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 84 | $13,875 |
| Pregabalin | 432 | $13,761 |
| MovantikNaloxegol Oxalate | 27 | $12,711 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta, Belbuca | $22 | $147,778196 claims |
| AbbVieBotox | $513 | $20,39616 claims |
| Redhill Biopharma Inc.Movantik | $16 | $12,71127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Fort Myers
- Jonathan DaitchFort Myers$39K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.